1.49
-0.135 (-8.31%)
-0.135 (-8.31%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 130,207 |
|
|||||
| News | - | ||||||
| Day High | 1.73 | Low High |
|||||
| Day Low | 1.4816 | ||||||
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cardiol Therapeutics Inc | CRDL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.135 | -8.31% | 1.49 | 18:20:43 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.70 | 1.4816 | 1.73 | 1.49 | 1.625 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 509 | 130,207 | $ 1.55 | $ 201,465 | - | 1.00 - 4.96 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:24:55 | 3 | $ 1.55 | USD |
Period:
Draw Mode:
Cardiol Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 92.27M | 61.93M | 61.93M | $ 61.06k | $ - | - | -3.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | - |
Cardiol Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRDL Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.29 | 1.70 | 1.28 | 1.47 | 103,867 | 0.20 | 15.5% |
| 1 Month | 1.29 | 1.70 | 1.2239 | 1.46 | 187,703 | 0.20 | 15.5% |
| 3 Months | 1.54 | 2.08 | 1.00 | 1.59 | 308,324 | -0.05 | -3.25% |
| 6 Months | 2.00 | 2.36 | 1.00 | 1.70 | 310,474 | -0.51 | -25.5% |
| 1 Year | 2.63 | 4.96 | 1.00 | 2.79 | 521,694 | -1.14 | -43.35% |
| 3 Years | 2.63 | 4.96 | 1.00 | 2.79 | 521,694 | -1.14 | -43.35% |
| 5 Years | 2.63 | 4.96 | 1.00 | 2.79 | 521,694 | -1.14 | -43.35% |
Cardiol Therapeutics Description
| Cardiol Therapeutics' lead product, CardiolRx, is a pharmaceutically produced oral cannabidiol formulation that is currently being evaluated in a Phase II/III multi-national study, the LANCER trial. Cardiol has also received IND authorization from the FDA to conduct clinical studies to evaluate CardiolRx in two orphan drug indications: (i) a Phase II multi-national trial in acute myocarditis; and (ii) a Phase II multicenter open-label pilot study in recurrent pericarditis. |